GlassScriptPhysician profile
Kevin M Brady
NPI 1154315810
$143,026.02
in general payments reported to CMS, 2019-2025
24 companies · $4,122 in 2025
The $4,122 reported for 2025 was more than what 79% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $11K · 2021: $12K · 2022: $33K · 2023: $46K · 2024: $21K · 2025: $4,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $54K · Travel and Lodging: $7,322 · Food and Beverage: $6,803 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $53,975.00 |
| Travel and Lodging | $7,322.29 |
| Food and Beverage | $6,803.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $134,595.74 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $3,141.32 | 2021-2025 | Corevalve Evolut R, Avalus, Penditure |
| Abiomed | $1,367.94 | 2022-2025 | Impella |
| Abbott Laboratories | $763.86 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Navitor |
| Medtronic Vascular, INC. | $758.36 | 2019-2020 | |
| Atricure, INC. | $595.30 | 2020-2025 | Synergy Ablation System |
| Saranas, INC. | $369.59 | 2022-2023 | |
| Bolton Medical INC | $332.11 | 2022 | |
| Getinge USA Sales, LLC | $265.25 | 2020-2025 | Vasoview Hemopro 2, Flixene, Vasoview Hemopro 2 |
| La Jolla Pharmaceutical Company | $144.24 | 2024 | Giapreza |
| Astrazeneca Pharmaceuticals LP | $134.99 | 2021 | |
| Saphena Medical, INC. | $134.83 | 2020-2022 | |
| Kestra Medical Technology Services, INC. | $81.48 | 2023 | Assure Wcd |
| Zoll Respicardia, INC. | $67.82 | 2023-2024 | Remede System |
| Smith+Nephew, INC. | $54.08 | 2025 | Pico 14, Pico 7 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $38.90 | 2023 | Cardiocel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.82 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.33 | 2022-2023 | Lifevest |
| Cvrx, INC. | $24.50 | 2024 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $22.90 | 2023 | |
| Ethicon US, LLC | $17.70 | 2025 | Dermabond Prineo, Evarrest, Stratafix |
| E.R. Squibb & Sons, L.L.C. | $16.14 | 2023 | Camzyos |
| Philips North America LLC | $16.01 | 2023 | |
| Baxter Healthcare | $14.81 | 2025 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.